Clinical Trial Update: Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

This update reports on a Phase 1 trial evaluating a monoclonal antibody therapy in combination with cyclosporine and paclitaxel for recurrent or refractory meta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Monoclonal antibody therapy
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: University of California, Davis | Conditions: Breast Cancer | Phase 1 | Status: UNKNOWN